Promoter Docon releases pledge on 7.94 crore Thyrocare shares
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts less than Nifty Microcap 250 and 1.5 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Docon Technologies, the promoter of Thyrocare, has released its pledge over 7,94,69,696 equity shares (49.93 percent of share capital) after its parent API Holdings fully repaid Non-Convertible Debentures worth INR 10,500 million on August 14, 2026. Docon continues to hold 51.02 percent in Thyrocare with no shares now under any encumbrance. The NCD repayment was partly funded through Docon's earlier sale of 1.57 crore Thyrocare shares.
Positive signal as pledge overhang on about half the promoter holding is removed and parent debt is fully cleared. No change in promoter ownership.